A study to evaluate safety and performance of Sodium Hyaluronate Ophthalmic Solutio
Phase 4
- Conditions
- Health Condition 1: PCS-
- Registration Number
- CTRI/2024/06/068514
- Lead Sponsor
- Kilitch Healthcare India Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects who are able to give voluntary, written informed consent to participate in this study.
Subjects who experience eye dryness, eye soreness/ burning, irritative sensation and discomfort
of eyes due to the continuous use of computer/ TV/ exposed pollution/ dry environment.
Exclusion Criteria
Anyone with known allergic reaction to Sodium Hyaluronate Ophthalmic Solution.
Subjects with existing eye infection.
History of ocular surgery. History or active signs of severe or serious ocular conditions such as
inflammatory corneal ulcers, recurrent erosions, and uveitis at any time.
Patients participating in any another clinical trial during study.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method